Dna X (SONM) Retained Earnings (2018 - 2026)

Dna X has reported Retained Earnings for 9 years, with the latest figure at -$297.6 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 5.1% year-over-year to -$297.6 million; the trailing twelve-month figure through Mar 2026 stood at -$297.6 million (down 5.1% YoY), and the FY2025 full-year result was -$304.3 million, down 7.28% from the prior year.
• Retained Earnings for Q1 2026 stood at -$297.6 million, up from -$304.3 million in the prior quarter.
• The five-year high for Retained Earnings was -$243.0 million in Q1 2022, with the low at -$304.3 million in Q4 2025.
• Historically, Retained Earnings has averaged -$265.6 million across 5 years, with a median of -$252.9 million in 2024.
• Annual changes were most pronounced in 2022 — Retained Earnings dropped 18.27% — and 2023, when it climbed 0.09%.
• Dna X's Retained Earnings stood at -$249.9 million in 2022, then dropped by 0.04% to -$250.0 million in 2023, then dropped by 13.46% to -$283.6 million in 2024, then fell by 7.28% to -$304.3 million in 2025, then gained by 2.19% to -$297.6 million in 2026.
• The last three Retained Earnings figures came in at -$297.6 million (Q1 2026), -$304.3 million (Q4 2025), and -$295.4 million (Q3 2025), per Business Quant data.